GF
Graf Finckenstein Friedrich
Directeur Médical
OtherM
内部人交易记录
高级管理人员基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Graf Finckenstein Friedrich, Directeur Médical. Insider active across 1 company, notably Iovance Biotherapeutics, INC.. In total, 18 filings have been logged. History available since 14 June 2022. The latest transaction was disclosed on 5 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Graf Finckenstein Friedrich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
7,813 股0Common StockSEC:0001104659-26-071897:0
3,976 股@ US$4.230.0008% mcap100.0% 占其流量Common StockSEC:0001104659-26-071897:1
62,497 股0Common StockSEC:0001104659-25-021055:0
2,813 股0Common StockSEC:0001104659-25-004204:0
3,906 股0Common StockSEC:0001104659-24-125542:0
2,813 股0Common StockSEC:0001104659-24-109277:0
3,907 股0Common StockSEC:0001104659-24-097490:0
2,813 股0Common StockSEC:0001104659-24-080617:0
3,906 股0Common StockSEC:0001104659-24-068773:0
2,812 股0Common StockSEC:0001104659-24-048428:0
15,623 股0Common StockSEC:0001104659-24-031578:0
2,813 股0Common StockSEC:0001104659-24-004865:0
2,813 股0Common StockSEC:0001104659-23-109940:0
2,813 股0Common StockSEC:0001104659-23-081714:0
2,812 股0Common StockSEC:0001104659-23-046843:0
11,248 股0Common StockSEC:0001104659-23-005048:0
19,690 股0Common StockSEC:0001104659-23-001607:0
19,690 股0Common StockSEC:0001104659-22-071967:0
About Graf Finckenstein Friedrich
Friedrich Graf Finckenstein serves as Chief Medical Officer at IOVANCE BIOTHERAPEUTICS, INC. In this role, he is responsible for overseeing the medical and clinical aspects of the company's operations. Friedrich brings his expertise to guide product development and ensure compliance with regulatory standards. His leadership is essential for innovation and continuous improvement in the healthcare solutions provided by the company.